Kvantify focuses on practical quantum computing applications in life sciences, specifically drug discovery. Its flagship product, Qrunch, executes quantum chemistry workflows on currently available quantum processors, overcoming the exponential scaling limits of classical molecular simulation. By providing accurate modeling of complex molecules, the platform helps researchers solve quantum-mechanical equations that are otherwise intractable for classical computers. Kvantify’s strategy centers on usability and immediate deployment, aiming to roll out Qrunch within organizations where it can address high-priority research needs and demonstrate measurable impact. The company plans to broaden access to the platform, solidifying its position at the intersection of quantum technology and pharmaceuticals. Kvantify recently secured €7 million in new capital to accelerate these goals, underscoring investor confidence in its approach.

Total raised

$19M

Funding rounds

2

Latest round

Seed

Latest activity

Mar 2026